| Drug Type Induced pluripotent stem cells (iPSC), Mesenchymal stem cell therapy | 
| Synonyms- | 
| Target | 
| Action modulators | 
| Mechanism IL-15 modulators(Interleukin-15 modulators), IL-7 modulators(interleukin 7 modulators) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neoplasms | Preclinical | United States  | 28 Apr 2025 | |
| Neoplasms | Preclinical | United States  | 28 Apr 2025 | |
| Neoplasms | Preclinical | United States  | 28 Apr 2025 | 





